wwwPosted Feb 19th 2008 9:30AM by Paul Foster
Filed under: Options
Onyx Pharma (NASDAQ: ONXX) is recently is down $9.23 to $35.70 in pre-open trading.
ONXX and its partner Bayer halted Phase 3 trials of Nexavar and after the company reported a larger than expected Q4 loss.
ONXX overall option implied volatility of 63 is above its 26-week average of 57 according to Track Data, suggesting larger price movement.
Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com
| # | Blogger | Posts | Cmts |
|---|---|---|---|
| 1 | Joseph Lazzaro | 114 | 0 |
| 2 | Tom Johansmeyer | 104 | 0 |
| 3 | Steven Mallas | 51 | 0 |
| 4 | Tom Taulli | 46 | 0 |
| 5 | Connie Madon | 46 | 0 |
| 6 | Steven Halpern | 37 | 0 |
| 7 | Mark Fightmaster | 35 | 0 |
| 8 | Trey Thoelcke | 35 | 0 |
| 9 | Paul Foster | 24 | 0 |
| 10 | Brian White | 24 | 0 |
| 11 | Zac Bissonnette | 23 | 0 |
| 12 | Brent Archer | 22 | 0 |
| 13 | Jon Ogg | 22 | 0 |
| 14 | Jim Cramer | 21 | 0 |
| 15 | Melly Alazraki | 21 | 0 |
| 16 | Eric Buscemi | 17 | 0 |
| 17 | Michael Fowlkes | 15 | 0 |
| 18 | Michael Shulman | 13 | 0 |
| 19 | Elizabeth Harrow | 11 | 0 |
| 20 | David Schepp | 9 | 0 |
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
Other Weblogs Inc. Network blogs you might be interested in:
Why do we have a weak dollar?
Holiday hiring slow for retailers
Closing Bell: What sell-off? (AIG, ABK, EPR, MBI, JAVA, ORCL, ERTS)
